
Fareston is a Selective
Estrogen Receptor Modulator (SERM), not unlike
its more popular cousins Nolvadex and Clomid. Just as we see with
Nolvadex, Fareston is used to treat breast cancer
in post-menopausal
women. It does this by exerting estrogen antagonistic effects in
certain tissue, most notably, breast tissue. This is actually the same
mechanism of action found in Nolvadex. This is why Nolvadex is often
recommended to bodybuilders who are trying to avoid gynocomastia
(growth of breast tissue in males). SERMs, in addition, have several
other well known effects in men, which are not simply limited to
preventing the abnormal growth of breast tissue.
At the hypothalamus and pituitary, estrogen acts in cooperation with
the male body’s negative feedback loop to send a signal to decrease the
secretion of LH, and when LH secretion is lowered, so are natural
testosterone levels. SERMs, like Fareston, possibly act as an estrogen
antagonist in the hypothalamus and pituitary, in order to increase
testosterone production. Thus, although it hasn’t been studied to any
great degree, it’s highly likely that Fareston is capable of increasing
testosterone in the same way that Nolvadex it, as it’s
androgenicity:estrogenicity ratio is 5x that of Nolvadex
[1].
It may
also be better than Nolvadex for reasons that are of particular
interest to steroid using athletes and bodybuilders.
Fareston differs from Nolvadex in several ways, however- even though
it’s very similar to it in others. Firstly, the risk of certain side
effects (although relatively rare with Nolvadex) is actually quite a
bit lower with Fareston. However unlikely these risks are in the first
place, the risk of stroke, pulmonary embolism, and cataract is probably
lower with Fareston than with Nolvadex. This is going to be of interest
to people who have issues with “floaters” in their vision, which is
sometimes caused by Nolvadex and
Clomid, as this product may represent
significantly less occular toxicity. It also differs slightly from
Nolvadex in its potent with regards to improving lipid (cholesterol)
profiles. In terms of improving
bone
mineral density, Fareston is
roughly equal to Nolvadex.
[2]
Although anecdotal evidence on this compound is rare,
bodybuilders who have already experimented with this stuff seem
satisfied. In my estimation, it would seem to be a more potent and
safer alternative to Nolvadex, for those who are worried about side
effects. I’m also predicting that it may provide a greater increase in
LH and therefore testosterone levels, in men when compared to Nolvadex
(when an appropriate dose of each is utilized). This makes its use a
strong possibility for PCT in the future, when studies on its ability
to elevate testosterone is more fully studied and understood.
Fareston would also make a welcome addition to a cycle where
Cholesterol issues may be a concern, or where something slightly
stronger than Nolvadex may be required to prevent gyno.